483
Michael J. McCartney, M.D.FDA 483 - Michael J. McCartney, M.D. - April 25, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Michael J. McCartney, M.D. in Methuen, MA, conducted from April 1 to April 25, 2024, identified a significant deviation in clinical trial conduct. The firm failed to follow its investigational plan, specifically by enrolling and treating two study subjects who did not meet the established eligibility criteria. This indicates a procedural lapse in ensuring proper subject selection for clinical investigations.
Open in Dashboard
ID · ded26ee4-cec2-4226-bc5f-1e168b086c23